Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
Filters
Save & Share
Clear Filters
- PI3K Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- CDK6
- Phase 2
Accepting patients
VMD-928
An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Learn more- Pan-RAF Kinase Inhibitor
- Phase 2